Journal
ARCHIVES OF MICROBIOLOGY
Volume 204, Issue 1, Pages -Publisher
SPRINGER
DOI: 10.1007/s00203-021-02723-7
Keywords
CRISPR; Cas9; Gene editing; Yeast; Fungi
Categories
Funding
- National Natural Science Foundation of China [81870778, 81600858, 81870759]
- Applied Basic Research Programs of Sichuan Province [2020YJ0227]
- Youth Grant of the Science and Technology Department of Sichuan Province, China [2017JQ0028]
- Innovative Research Team Program of Sichuan Province
- Fund of State Key Laboratory of Oral Diseases [SKLOD201913]
Ask authors/readers for more resources
Genome editing technology has made rapid progress in recent years. The limitations of traditional gene-editing methods have led to the development of the CRISPR/Cas system, which has become the dominant genomic editing technology in academia and the pharmaceutical industry due to its high efficiency, simple design, and wide applications.
Genome editing technology has progressed rapidly in recent years. Although traditional gene-editing methods, including homologous recombination, zinc finger endonucleases, and transcription activator-like effector nucleases, have substantial implications for research in genetics and molecular biology, but they have remarkable limitations, including their low efficiency, high error rate, and complex design. A new gene-editing technology, the CRISPR/Cas system, was developed based on studies of archaeal and bacterial immune responses to viruses. Owing to its high target efficiency, simple primer design, and wide applications, the CRISPR/Cas system, whose developers were awarded the Nobel Prize in Chemistry in 2020, has become the dominant genomic editing technology in academia and the pharmaceutical industry. Here, we briefly introduce the CRISPR/Cas system and its main applications for genome engineering, metabolic engineering, and transcriptional regulation in yeast, filamentous fungi, and macrofungi. The polygene and polyploid editing, construction of yeast chromosomes, yeast library creation, regulation of metabolic pathways, and CRISPR activation/CRISPR interference systems are mainly summarized and discussed. The potential applications for the treatment of fungal infections and the further transformation and application of the CRISPR/Cas system in fungi are also proposed and discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available